E
Eric A. Mellon
Researcher at University of Miami
Publications - 96
Citations - 3311
Eric A. Mellon is an academic researcher from University of Miami. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 20, co-authored 77 publications receiving 2458 citations. Previous affiliations of Eric A. Mellon include University of Pennsylvania & Alfred I. duPont Hospital for Children.
Papers
More filters
Journal ArticleDOI
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker,Berend R. Beumer,Eran Sadot,Lysiane Marthey,Jason E. Faris,Eric A. Mellon,Bassel F. El-Rayes,Andrea Wang-Gillam,Jill Lacy,Peter J. Hosein,Sing Yu Moorcraft,Thierry Conroy,Florian Hohla,Peter J. Allen,Julien Taieb,Theodore S. Hong,Ravi Shridhar,Ian Chau,Casper H.J. van Eijck,Bas Groot Koerkamp +19 more
TL;DR: Patients with locally advanced pancreatic cancer treated with FOLFIRINOX had a median overall survival of 24·2 months-longer than that reported with gemcitabine (6-13 months).
Journal ArticleDOI
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
Jacob G. Scott,Anders Berglund,Michael J. Schell,Ivaylo B. Mihaylov,William J. Fulp,Binglin Yue,Eric A. Welsh,Jimmy J. Caudell,Kamran Ahmed,Tobin S Strom,Eric A. Mellon,Puja Venkat,Peter A.S. Johnstone,John A. Foekens,Jae K. Lee,Eduardo G. Moros,William S. Dalton,Steven A. Eschrich,Howard McLeod,Louis B. Harrison,Javier F. Torres-Roca +20 more
TL;DR: A GARD-based clinical model could allow the individualisation of radiotherapy dose to tumour radiosensitivity and could provide a framework to design genomically-guided clinical trials in radiation oncology.
Journal ArticleDOI
Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated
Michael D. Chuong,Gregory M. Springett,J. Freilich,Catherine K. Park,Jill Weber,Eric A. Mellon,Pamela J. Hodul,Mokenge P. Malafa,Kenneth L. Meredith,Sarah E. Hoffe,Ravi Shridhar +10 more
TL;DR: SBRT safely facilitates margin-negative resection in patients with BRPC pancreatic cancer while maintaining a high rate of LC in unresectable patients and these data support the expanded implementation of SBRT for pancreaticcancer.
Journal ArticleDOI
Sodium and T1ρ MRI for molecular and diagnostic imaging of articular cartilage
Arijitt Borthakur,Eric A. Mellon,Sampreet Niyogi,Walter R Witschey,J. Bruce Kneeland,Ravinder Reddy +5 more
TL;DR: Both sodium magnetic resonance (MR) and T1ρ relaxation mapping aimed at measuring molecular changes in cartilage for the diagnostic imaging of osteoarthritis are reviewed.
Journal ArticleDOI
Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer.
Soumon Rudra,Naomi Jiang,Stephen A. Rosenberg,Jeffrey R. Olsen,Michael C. Roach,Leping Wan,Lorraine Portelance,Eric A. Mellon,Anna M.E. Bruynzeel,Frank J. Lagerwaard,Michael F. Bassetti,Parag J. Parikh,Percy Lee +12 more
TL;DR: Outcomes of inoperable pancreatic cancer patients treated using MRgRT with and without dose escalation are evaluated.